587-62-2

Usage

Uses

Used in Pharmaceutical Industry:
L-DOPA is utilized as a medication for the treatment of Parkinson's disease and other conditions related to dopamine deficiency. It helps alleviate symptoms by increasing the levels of dopamine in the brain.
Used in Neurological Disorder Treatment:
L-DOPA has been studied for its potential use in treating depression, schizophrenia, and other neurological disorders, due to its role in neurotransmission and its influence on brain chemistry.
Used in Cosmetics Industry:
As an important compound in the biosynthesis of melanin, L-DOPA is also used in the cosmetics industry for its effects on skin and hair pigmentation, contributing to the development of products that address color-related cosmetic concerns.

Upstream product

• 7636-27-3 3,5-dimethoxy-phenylalanine 
• 1097-21-8 Azalactone of α-benzoylamino-β-(3,5-dimethoxyphenyl)acrylic acid 
• 17213-57-9 3,5-dimethoxybenzoyl chloride 
• 7311-34-4 3,5-dimethoxybenzaldehdye 

Relevant academic research and scientific papers

NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS

The invention relates to a compound of the formula (I): in which k and j are independently 0 or 1, Y is a macrocycle in which the cycle includes 9 to 36 carbon atoms and is functionalised by three amino functions and by a chain for attaching the spacer arm Z via an X bond, Rc is a binding pattern with a receptor of the TNF superfamily, X is a chemical function for binding the Y group to the space arm, and Z is a bi-, tri- or tetra-functional spacer arm.

NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS

The invention concerns a compound of formula (I), wherein Y represents a macrocycle whereof the cycle comprises 9 to 36 atoms, and is functionalized by three amine or COOH functions; Rc represents a group of formula H—Xa—Xb—Xc—Xd—Xe—(Xf)i—, wherein i represents 0 or 1, Xn is in particular selected among lysine, arginine, ornithine residues, Xb is in particular selected among glycine, asparagine, L-proline or D-proline residues, Xc et Xd are in particular selected among tyrosine, phenylalanine or 3-nitrotyrosine residues, Xe et Xf are in particular selected among the following amino acid residues: NH2—(CH2)n—COOH, n ranging from 1 to 10 or NH2—(CH2—CH2—O)m—CH2CH2COOH, m ranging from 3 to 6, provided that one at least of the amino acid residues Xa, Xb, Xc and Xd is different from the corresponding amino acid in the sequence of the natural CD40 143Lys-Gly-Tyr-Tyr146 fragment